Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 13.76% and Operating profit at -11.83% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 8.20% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 13.76% and Operating profit at -11.83% over the last 5 years
3
With ROE of 10.51%, it has a fair valuation with a 1.45 Price to Book Value
Stock DNA
Other Agricultural Products
CNY 10,171 Million (Mid Cap)
14.00
NA
2.93%
0.28
10.51%
1.45
Revenue and Profits:
Net Sales:
4,654 Million
(Quarterly Results - Jun 2025)
Net Profit:
238 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
5.17%
0%
5.17%
6 Months
6.46%
0%
6.46%
1 Year
1.17%
0%
1.17%
2 Years
-10.01%
0%
-10.01%
3 Years
-22.68%
0%
-22.68%
4 Years
-24.7%
0%
-24.7%
5 Years
-49.01%
0%
-49.01%
Tecon Biology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
13.76%
EBIT Growth (5y)
-11.83%
EBIT to Interest (avg)
1.37
Debt to EBITDA (avg)
2.21
Net Debt to Equity (avg)
0.42
Sales to Capital Employed (avg)
1.38
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
49.64%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.09%
ROE (avg)
8.20%
Valuation key factors
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
1.45
EV to EBIT
14.69
EV to EBITDA
7.10
EV to Capital Employed
1.35
EV to Sales
0.67
PEG Ratio
0.07
Dividend Yield
2.93%
ROCE (Latest)
9.19%
ROE (Latest)
10.51%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
4,653.90
4,168.10
11.66%
Operating Profit (PBDIT) excl Other Income
499.00
409.00
22.00%
Interest
40.70
39.80
2.26%
Exceptional Items
0.10
-0.00
Consolidate Net Profit
238.20
171.40
38.97%
Operating Profit Margin (Excl OI)
58.80%
44.10%
1.47%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 11.66% vs 2.29% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 38.97% vs 309.07% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
17,128.80
18,979.00
-9.75%
Operating Profit (PBDIT) excl Other Income
1,633.40
-491.40
432.40%
Interest
193.30
249.40
-22.49%
Exceptional Items
-40.80
-36.60
-11.48%
Consolidate Net Profit
596.40
-1,516.40
139.33%
Operating Profit Margin (Excl OI)
42.70%
-68.80%
11.15%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -9.75% vs 11.97% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 139.33% vs -898.11% in Dec 2023
About Tecon Biology Co., Ltd. 
Tecon Biology Co., Ltd.
Other Agricultural Products
No Details Available.
Company Coordinates 
No Company Details Available






